Although numerous data have established the proatherogenic effects, a recent study revealed a paradoxical result that IL-22 protects against WD-induced atherosclerosis in LDLR−/− mice by regulating intestinal microbial homeostasis (Fatkhullina et al. 2018). Here, IL22 is linked to Wilson disease.